1. Home
  2. MCI vs CADL Comparison

MCI vs CADL Comparison

Compare MCI & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barings Corporate Investors

MCI

Barings Corporate Investors

HOLD

Current Price

$17.55

Market Cap

362.0M

Sector

Finance

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$6.48

Market Cap

357.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCI
CADL
Founded
1971
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
362.0M
357.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MCI
CADL
Price
$17.55
$6.48
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$19.00
AVG Volume (30 Days)
45.5K
1.7M
Earning Date
01-01-0001
05-14-2026
Dividend Yield
8.46%
N/A
EPS Growth
N/A
58.62
EPS
1.82
N/A
Revenue
N/A
$125,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.24
$4.34
52 Week High
$23.00
$7.66

Technical Indicators

Market Signals
Indicator
MCI
CADL
Relative Strength Index (RSI) 40.88 60.53
Support Level $17.27 $4.80
Resistance Level $18.19 $7.66
Average True Range (ATR) 0.34 0.53
MACD 0.07 0.01
Stochastic Oscillator 41.30 58.13

Price Performance

Historical Comparison
MCI
CADL

About MCI Barings Corporate Investors

Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations, including bank loans and mezzanine debt instruments. The Trust typically purchases these investments, which are not publicly tradable, directly from their issuers in private placement transactions, and the investments are typically made to small or middle market companies.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: